StockData
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. (NERV) stock

NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$2.18+0.02 (+0.93%)

Close on Nov 18, 2026Market cap $104.09MP/E –Yield –

Minerva Neurosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Minerva Neurosciences's market cap was $120.90M on Nov 11, 2026, against $29.23M a year earlier. Over the last 5 years it ranged from $8.49M to $285.61M, with a median of $22.31M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$120.90M+330.0%
2025Dec 31, 2025$28.11M+81.0%
2024Dec 31, 2024$15.54M-63.9%
2023Dec 29, 2023$43.01M+406.5%
2022Dec 30, 2022$8.49M-75.2%
2021Dec 31, 2021$34.22M-65.7%
2020Dec 31, 2020$99.86M-64.0%
2019Dec 31, 2019$277.47M+6.0%
2018Dec 31, 2018$261.83M+11.8%
2017Dec 29, 2017$234.14M-42.8%
2016Dec 30, 2016$408.98M+172.6%
2015Dec 31, 2015$150.06M+35.2%
2014Dec 31, 2014$111.01M–

More Minerva Neurosciences figures

See a number that looks wrong?